Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

SEEL – Seelos Therapeutics Inc

Float Short %

46.13

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

989.44

EPS This/Next Y

Price

0.39

Target Price

Analyst Recom

1

Performance Q

-85.02

Relative Volume

Beta

1.87

Ticker: SEEL



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-17SEEL0.39N/AN/A0
2025-11-18SEEL0.39N/AN/A0
2025-11-19SEEL0.39N/AN/A0
2025-11-20SEEL0.39N/AN/A0
2025-11-21SEEL0.39N/AN/A0
2025-11-24SEEL0.39N/AN/A0
2025-11-25SEEL0.39N/AN/A0
2025-11-26SEEL0.39N/AN/A0
2025-12-01SEEL0.39N/AN/A0
2025-12-02SEEL0.39N/AN/A0
2025-12-03SEEL0.39N/AN/A0
2025-12-04SEEL0.39N/AN/A0
2025-12-05SEEL0.39N/AN/A0
2025-12-08SEEL0.39N/AN/A0
2025-12-09SEEL0.39N/AN/A0
2025-12-10SEEL0.39N/AN/A0
2025-12-11SEEL0.39N/AN/A0
2025-12-12SEEL0.39N/AN/A0
2025-12-15SEEL0.39N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



No data found



No data found

[stock_market_widget type="chart" template="candlestick" assets="SEEL" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

-1.48

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

1.87

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

14

Growth Score

Sentiment Score

9

Actual DrawDown %

100

Max Drawdown 5-Year %

-100

Target Price

P/E

Forward P/E

PEG

P/S

0.37

P/B

P/Free Cash Flow

EPS

351.04

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-33.1

Return on Equity vs Industry %

-20.9

EPS 1 7Days Diff

4.1

EPS 1 30Days Diff

4.09

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”SEEL” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”SEEL” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”SEEL” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”SEEL” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”SEEL” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”SEEL” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”SEEL” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Seelos Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 8
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-004, an gene therapy targeting gene and alpha synuclein; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; SLS-007, a peptidic inhibitor for NACore Parkinson disease; and SLS-009, a protein targeted autophagy for Alzheimer disease. Seelos Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York. On November 16, 2024, Seelos Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
stock quote shares SEEL – Seelos Therapeutics Inc Stock Price stock today
news today SEEL – Seelos Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch SEEL – Seelos Therapeutics Inc yahoo finance google finance
stock history SEEL – Seelos Therapeutics Inc invest stock market
stock prices SEEL premarket after hours
ticker SEEL fair value insiders trading